NCT00726336View on ClinicalTrials.gov

GSK1349572 Drug Interaction With Tenofovir

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

October 31, 2008

Conditions
Healthy Subjects
Interventions
DRUG

GSK1349572 and tenofovir

Trial Locations (1)

14202

GSK Investigational Site, Buffalo

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY